Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Metagenics' Research on the Safety and Efficacy of Hops-derived Anti-inflammatory Compounds Published in Peer-Reviewed, Scientific Journal
Metagenics, Inc. has announced the publication of a scientific paper, “Safety, efficacy and anti-inflammatory activity of rho iso-alpha-acids from hops,” in the May issue of Phytochemistry, the International Journal of Plant Chemistry, Plant Biochemistry and Molecular Biology.
- Advitech Announces Positive Clinical and Pre-Clinical Results
Advitech Inc. has announced positive results from its clinical trials on psoriasis, eczema and pre-clinical program on wound healing.
- Advitech Announces Positive Clinical and Pre-Clinical Results
Advitech Inc. has announced positive results from its clinical trials on psoriasis, eczema and pre-clinical program on wound healing.
- Resveratrol Found to Improve Health, But Not Longevity in Aging Mice on Standard Diet
A study, published in Cell Metabolism, conducted and supported in part by the National Institute on Aging (NIA), part of the National Institutes of Health, following up 2006 findings that resveratrol improves health and longevity of overweight, aged mice, has determined that resveratrol slows age-related deterioration and functional decline of mice on a standard diet, but does not increase longevity when started at middle age.
- Resveratrol Found to Improve Health, But Not Longevity in Aging Mice on Standard Diet
A study, published in Cell Metabolism, conducted and supported in part by the National Institute on Aging (NIA), part of the National Institutes of Health, following up 2006 findings that resveratrol improves health and longevity of overweight, aged mice, has determined that resveratrol slows age-related deterioration and functional decline of mice on a standard diet, but does not increase longevity when started at middle age.
- MELTDOWN clinical trial results presented at the 5th annual International Society of Sports Nutrition Conference
In a clinical trial performed at the College of New Jersey, investigators discovered that the weight loss supplement, VPX’s MELTDOWN® produced statistically significant increases in metabolic rate. The results of this investigation were presented at the 5th annual ISSN Conference and Expo and will be published in the Journal of the International Society of Sports Nutrition.
- MELTDOWN clinical trial results presented at the 5th annual International Society of Sports Nutrition Conference
In a clinical trial performed at the College of New Jersey, investigators discovered that the weight loss supplement, VPX’s MELTDOWN® produced statistically significant increases in metabolic rate. The results of this investigation were presented at the 5th annual ISSN Conference and Expo and will be published in the Journal of the International Society of Sports Nutrition.
- MELTDOWN clinical trial results presented at the 5th annual International Society of Sports Nutrition Conference
In a clinical trial performed at the College of New Jersey, investigators discovered that the weight loss supplement, VPX’s MELTDOWN® produced statistically significant increases in metabolic rate. The results of this investigation were presented at the 5th annual ISSN Conference and Expo and will be published in the Journal of the International Society of Sports Nutrition.
- A Border-Free Collaboration for Natural Health: Biotanika and NRC Join Forces in an R&D Agreement
Biotanika and the National Research Council Canada (NRC) have signed a collaborative research agreement bridging expertise from a private company and a federal R&D organization, and involving teams drawn from Quebec and Prince Edward Island.
- A Border-Free Collaboration for Natural Health: Biotanika and NRC Join Forces in an R&D Agreement
Biotanika and the National Research Council Canada (NRC) have signed a collaborative research agreement bridging expertise from a private company and a federal R&D organization, and involving teams drawn from Quebec and Prince Edward Island.
- A Border-Free Collaboration for Natural Health: Biotanika and NRC Join Forces in an R&D Agreement
Biotanika and the National Research Council Canada (NRC) have signed a collaborative research agreement bridging expertise from a private company and a federal R&D organization, and involving teams drawn from Quebec and Prince Edward Island.
- A Border-Free Collaboration for Natural Health: Biotanika and NRC Join Forces in an R&D Agreement
Biotanika and the National Research Council Canada (NRC) have signed a collaborative research agreement bridging expertise from a private company and a federal R&D organization, and involving teams drawn from Quebec and Prince Edward Island.
- A Border-Free Collaboration for Natural Health: Biotanika and NRC Join Forces in an R&D Agreement
Biotanika and the National Research Council Canada (NRC) have signed a collaborative research agreement bridging expertise from a private company and a federal R&D organization, and involving teams drawn from Quebec and Prince Edward Island.
- Published Study Confirms Safety of InterHealth’s Super CitriMax®
Results of a study published in the June issue of Toxicology Mechanisms and Methods, further affirms the long-term safety of Super CitriMax®.
- Published Study Confirms Safety of InterHealth’s Super CitriMax®
Results of a study published in the June issue of Toxicology Mechanisms and Methods, further affirms the long-term safety of Super CitriMax®.
- Published Study Confirms Safety of InterHealth’s Super CitriMax®
Results of a study published in the June issue of Toxicology Mechanisms and Methods, further affirms the long-term safety of Super CitriMax®.
- Clinical Trial on Hospitalized Children Suffering from Lead Poisoning Reveals the Safety and Effectiveness of Modified Citrus Pectin (MCP)
EcoNugenics announces the results of a collaborative study with the U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS) that reveals the effectiveness and safety of modified citrus pectin (MCP; PectaSol) in dramatically lowering lead toxicity in children who were suffering from severe lead poisoning.
- Clinical Trial on Hospitalized Children Suffering from Lead Poisoning Reveals the Safety and Effectiveness of Modified Citrus Pectin (MCP)
EcoNugenics announces the results of a collaborative study with the U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS) that reveals the effectiveness and safety of modified citrus pectin (MCP; PectaSol) in dramatically lowering lead toxicity in children who were suffering from severe lead poisoning.
- Danone Research announces further progress in the development of its Alzheimer’s product Souvenaid (TM)
Danone Research announces that it has taken an important step forward in the development program for its Alzheimer’s product SouvenaidTM with the successful completion of a first clinical trial.
- Danone Research announces further progress in the development of its Alzheimer’s product Souvenaid (TM)
Danone Research announces that it has taken an important step forward in the development program for its Alzheimer’s product SouvenaidTM with the successful completion of a first clinical trial.
- Danone Research announces further progress in the development of its Alzheimer’s product Souvenaid (TM)
Danone Research announces that it has taken an important step forward in the development program for its Alzheimer’s product SouvenaidTM with the successful completion of a first clinical trial.
- Trace Minerals Research Invites Industry Leaders To Serve On Research Advisory Board
Trace Minerals Research (TMR) has announced the acceptance of Dr. Alexander G. Schauss, Ph.D., FACN, and Dr. Chris D. Meletis, N.D. today to serve as members of its recently established Scientific Research Advisory Board.
- Trace Minerals Research Invites Industry Leaders To Serve On Research Advisory Board
Trace Minerals Research (TMR) has announced the acceptance of Dr. Alexander G. Schauss, Ph.D., FACN, and Dr. Chris D. Meletis, N.D. today to serve as members of its recently established Scientific Research Advisory Board.
- Trace Minerals Research Invites Industry Leaders To Serve On Research Advisory Board
Trace Minerals Research (TMR) has announced the acceptance of Dr. Alexander G. Schauss, Ph.D., FACN, and Dr. Chris D. Meletis, N.D. today to serve as members of its recently established Scientific Research Advisory Board.
- Trace Minerals Research Invites Industry Leaders To Serve On Research Advisory Board
Trace Minerals Research (TMR) has announced the acceptance of Dr. Alexander G. Schauss, Ph.D., FACN, and Dr. Chris D. Meletis, N.D. today to serve as members of its recently established Scientific Research Advisory Board.
- Human Clinical Study Confirms Frutarom’s Neuravena® Enhances Mental Fitness and Stress Resistance
In-vitro and animal trials have demonstrated that Frutarom’s Neuravena® (EFLA® 955) wild green oat extract has a significant, positive effect on brain activity, enhancing mental fitness and stress resistance.
- Human Clinical Study Confirms Frutarom’s Neuravena® Enhances Mental Fitness and Stress Resistance
In-vitro and animal trials have demonstrated that Frutarom’s Neuravena® (EFLA® 955) wild green oat extract has a significant, positive effect on brain activity, enhancing mental fitness and stress resistance.
- Human Clinical Study Confirms Frutarom’s Neuravena® Enhances Mental Fitness and Stress Resistance
In-vitro and animal trials have demonstrated that Frutarom’s Neuravena® (EFLA® 955) wild green oat extract has a significant, positive effect on brain activity, enhancing mental fitness and stress resistance.
- Human Clinical Study Confirms Frutarom’s Neuravena® Enhances Mental Fitness and Stress Resistance
In-vitro and animal trials have demonstrated that Frutarom’s Neuravena® (EFLA® 955) wild green oat extract has a significant, positive effect on brain activity, enhancing mental fitness and stress resistance.
- Human Clinical Study Confirms Frutarom’s Neuravena® Enhances Mental Fitness and Stress Resistance
In-vitro and animal trials have demonstrated that Frutarom’s Neuravena® (EFLA® 955) wild green oat extract has a significant, positive effect on brain activity, enhancing mental fitness and stress resistance.
- According To New Study, Capros® Offers Different Antioxidant Properties Than Other Amla Extracts
According to a company study, the preparation of Capros® maintains the integrity of its antioxidant profile, allowing for more effective reduction of oxidative stress in the body when compared to other amla samples.
- According To New Study, Capros® Offers Different Antioxidant Properties Than Other Amla Extracts
According to a company study, the preparation of Capros® maintains the integrity of its antioxidant profile, allowing for more effective reduction of oxidative stress in the body when compared to other amla samples.
- New Study: Mirtogenol(TM) Lowers High Intraocular Hypertension
New research published in the July issue of Molecular Vision demonstrates that natural supplement Mirtogenol(TM), a combination of standardized bilberry extract Mirtoselect® and French maritime pine bark extract Pycnogenol®, lowers high intraocular pressure (IOP), which significantly reduces the likelihood of developing glaucoma.
- New Study: Mirtogenol(TM) Lowers High Intraocular Hypertension
New research published in the July issue of Molecular Vision demonstrates that natural supplement Mirtogenol(TM), a combination of standardized bilberry extract Mirtoselect® and French maritime pine bark extract Pycnogenol®, lowers high intraocular pressure (IOP), which significantly reduces the likelihood of developing glaucoma.
- New Study: Mirtogenol(TM) Lowers High Intraocular Hypertension
New research published in the July issue of Molecular Vision demonstrates that natural supplement Mirtogenol(TM), a combination of standardized bilberry extract Mirtoselect® and French maritime pine bark extract Pycnogenol®, lowers high intraocular pressure (IOP), which significantly reduces the likelihood of developing glaucoma.
- Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States.
- Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States.
- Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States.
- Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States.
- Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States.
- Study Proves Beneficial Effects of Phosphatidylserine (PS) on Stress Management
A study published today in the Journal of the International Society of Sports Nutrition indicates that the consumption of a phosphatidylserine (PS) can help to effectively manage exercise induced stress and promote healthy free testosterone levels.
- Study Proves Beneficial Effects of Phosphatidylserine (PS) on Stress Management
A study published today in the Journal of the International Society of Sports Nutrition indicates that the consumption of a phosphatidylserine (PS) can help to effectively manage exercise induced stress and promote healthy free testosterone levels.
- Study Proves Beneficial Effects of Phosphatidylserine (PS) on Stress Management
A study published today in the Journal of the International Society of Sports Nutrition indicates that the consumption of a phosphatidylserine (PS) can help to effectively manage exercise induced stress and promote healthy free testosterone levels.
- Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer
Senomyx, Inc. (SNMX) has announced that it has initiated development activities for a new sucrose enhancer, S6973, where taste tests show the product enabling the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar.
- Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer
Senomyx, Inc. (SNMX) has announced that it has initiated development activities for a new sucrose enhancer, S6973, where taste tests show the product enabling the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar.
- Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer
Senomyx, Inc. (SNMX) has announced that it has initiated development activities for a new sucrose enhancer, S6973, where taste tests show the product enabling the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar.
- Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer
Senomyx, Inc. (SNMX) has announced that it has initiated development activities for a new sucrose enhancer, S6973, where taste tests show the product enabling the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar.
- Experts continue to cite Bifantis as promising probiotic treatment for Irritable Bowel Syndrome
Two new review articles that cover therapeutic approaches to irritable bowel syndrome (IBS) in the July issue of Nutrition in Clinical Practice, cite growing evidence that probiotics, and specifically Bifidobacterium infantis 35624 (Bifantis®), are effective in helping manage IBS.
- Experts continue to cite Bifantis as promising probiotic treatment for Irritable Bowel Syndrome
Two new review articles that cover therapeutic approaches to irritable bowel syndrome (IBS) in the July issue of Nutrition in Clinical Practice, cite growing evidence that probiotics, and specifically Bifidobacterium infantis 35624 (Bifantis®), are effective in helping manage IBS.
- Prestigious Confirmation of Low-Carb Diet Poised to Revitalize Weight Loss Nutraceutical Industry
A study published in the July 17th, 2008 edition of the New England Journal of Medicine1 showed clearly that a low-carb diet helped people lose more weight than a Mediterranean-style diet and the common low-fat diet. In addition, researchers discovered that a low-carb diet also helped improve healthy cholesterol ratios.
- Prestigious Confirmation of Low-Carb Diet Poised to Revitalize Weight Loss Nutraceutical Industry
A study published in the July 17th, 2008 edition of the New England Journal of Medicine1 showed clearly that a low-carb diet helped people lose more weight than a Mediterranean-style diet and the common low-fat diet. In addition, researchers discovered that a low-carb diet also helped improve healthy cholesterol ratios.
- Prestigious Confirmation of Low-Carb Diet Poised to Revitalize Weight Loss Nutraceutical Industry
A study published in the July 17th, 2008 edition of the New England Journal of Medicine1 showed clearly that a low-carb diet helped people lose more weight than a Mediterranean-style diet and the common low-fat diet. In addition, researchers discovered that a low-carb diet also helped improve healthy cholesterol ratios.
- New study suggests Carnipure(TM) supplementation improves bone mineral density
A new study released by the University of Connecticut, USA, suggests, that Carnipure(TM) tartrate supplementation can slow down bone loss and improve bone microstructural properties by decreasing bone turnover in aged ovariectomized rats.
- New study suggests Carnipure(TM) supplementation improves bone mineral density
A new study released by the University of Connecticut, USA, suggests, that Carnipure(TM) tartrate supplementation can slow down bone loss and improve bone microstructural properties by decreasing bone turnover in aged ovariectomized rats.
- New study suggests Carnipure(TM) supplementation improves bone mineral density
A new study released by the University of Connecticut, USA, suggests, that Carnipure(TM) tartrate supplementation can slow down bone loss and improve bone microstructural properties by decreasing bone turnover in aged ovariectomized rats.
- New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol
In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers.
- New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol
In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers.
- New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol
In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers.
- 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy
a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily.
- 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy
a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily.
- 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy
a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Pediatrics Journal Publishes Positive Safety Results of First Children's Trial Involving COLD-fX(R)
Pediatrics - the official journal of the American Academy of Pediatrics, has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®. The trial, designed to measure safety and tolerability, showed COLD-fX is safe for children.
- Pediatrics Journal Publishes Positive Safety Results of First Children's Trial Involving COLD-fX(R)
Pediatrics - the official journal of the American Academy of Pediatrics, has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®. The trial, designed to measure safety and tolerability, showed COLD-fX is safe for children.
- Pediatrics Journal Publishes Positive Safety Results of First Children's Trial Involving COLD-fX(R)
Pediatrics - the official journal of the American Academy of Pediatrics, has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®. The trial, designed to measure safety and tolerability, showed COLD-fX is safe for children.
- Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show
Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev.
- Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show
Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
White Bear Lake, MN – A study published by Dr. Mariangela Rondanelli, University of Pavia, Italy, in the July 2008 issue of the prestigious British Journal of Nutrition, proves that PhosphoLean™ NOPE + EGCG can significantly improve a person’s ability to stay on their stressful diet and successfully lose weight. Clearly, it has been shown that one third of dieters drop off their diets in the crucial first few weeks, and as a result, they experience little if any success. It is well known that in any long term diet, patient compliance is crucial to the successful treatment of obesity.
The study involving 138 overweight and obese men and women on an eight week low calorie diet, showed that the PhosphoLean™ NOPE + EGCG group experienced only a 6% drop out rate vs. a 27% drop out rate for the placebo group. In addition, the treatment group had improved insulin resistance, greater feelings of fullness, decreased depressive symptoms, and decreased binge eating feelings, all at statistically significant levels.
Scott Hagerman, president of Chemi Nutra said, “A recently published meta-analysis of one to four year randomized controlled trials of several well known diet compounds resulted in average weight reductions of less than 5 kg, even though the studies preselected subjects for their ability to adhere to the treatments. Due to the high stress of the hypo-caloric diets, both depression rates and attrition rates were very,very high, thus compromising the validity of the studies. In contrast, our PhosphoLean™ NOPE + EGCG was proven to safely and effectively help dieters stay on their diets, and in addition provided several other major physiological benefits. With the overweightness and obesity epidemics that threaten life expectancy and quality of life in the U.S., our PhosphoLean™ NOPE + EGCG specialty ingredient will hopefully help many people to better manage their bodyweight and lead a healthier lifestyle.”
The mode of action for PhosphoLean™ NOPE + EGCG is based on the active compound N-oleyl-ethanolamine (NOE), a newly discovered lipid mediator liberated from NOPE upon ingestion. NOE binds to a unique cell receptor class called peroxisome-proliferator-activated receptor-α (PPAR-α) found in the intestinal tract. These receptors, when activated, signal the brain center to decrease appetite and hence reduce food intake, leading to eventual loss of bodyweight. Currently there is a tremendous amount of research and development in this arena involving the manipulation of appetite via this intriguing cell-signaling mechanism.
Chemi Nutra is the US business unit of parent company Chemi S.p.A., a privately held pharmaceutical and nutraceutical company based in Milan, Italy. Chemi, with cGMP certified manufacturing facilities in Italy and Brazil, is best known in the US nutritional arena for its introduction of phosphatidylserine (PS), the popular dietary supplement which has been granted two health claims by the FDA, and is used to enhance learning, memory, and concentration.
-- End --
|